GE HEALTHCARE TECHNOLOGIES INC. (GEHC) Operating Margin
- Operating margin · 12 months: Value 12.63%; Formula and calculation Operating income / revenue. Period ending 2026-03-31..
Operating margin
Overview →Financial period ending 2026-03-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | 12.63% | Operating income / revenue. Period ending 2026-03-31. $2.65B ÷ $20.98B × 100 ≈ 12.63% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 2.65B USD | Operating Income (Loss) |
| Revenue | 20.98B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | |
| Research and development | 1.26B USD | Research and Development Expense |
| Selling, general and administration | 4.30B USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2.65B | $20.98B | (m) | $1.26B | $4.30B | 12.63% |
| 2025-12-31 | $2.76B | $20.63B | (m) | $1.26B | $4.22B | 13.40% |
| 2025-09-30 | $2.74B | $20.25B | (m) | $1.28B | $4.24B | 13.52% |
| 2025-06-30 | $2.76B | $19.97B | (m) | $1.31B | $4.23B | 13.82% |
| 2025-03-31 | $2.71B | $19.80B | (m) | $1.33B | $4.27B | 13.71% |
| 2024-12-31 | $2.63B | $19.67B | (m) | $1.31B | $4.27B | 13.34% |
| 2024-09-30 | $2.51B | $19.56B | (m) | $1.28B | $4.29B | 12.85% |
| 2024-06-30 | $2.45B | $19.52B | (m) | $1.29B | $4.25B | 12.57% |
| 2024-03-31 | $2.42B | $19.50B | (m) | $1.26B | $4.26B | 12.39% |
| 2023-12-31 | $2.44B | $19.55B | (m) | $1.21B | $4.28B | 12.45% |
| 2023-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $2.52B | $18.34B | (m) | $1.03B | $3.63B | 13.75% |
| 2022-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $2.79B | $17.59B | (m) | $816.00M | $3.56B | 15.89% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.